Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tegaserod. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR4 known ✓ | Q13639 | 1/20 | 0.66 |
| ▸ | HTR1A | P08908 | 5/20 | 0.66 |
| ▸ | HTR2C | P28335 | 5/20 | 0.66 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.66 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.66 |
| ▸ | DRD2 | P14416 | 2/20 | 0.66 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.66 |
| ▸ | DRD4 | P21917 | 2/20 | 0.66 |
| ▸ | HTR2A | P28223 | 2/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.66 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.66 |
| ▸ | DRD3 | P35462 | 2/20 | 0.66 |
| ▸ | HTR2B | P41595 | 2/20 | 0.66 |
| ▸ | HTR3A | P46098 | 2/20 | 0.66 |
| ▸ | HTR5A | P47898 | 2/20 | 0.66 |
| ▸ | HTR6 | P50406 | 2/20 | 0.66 |
| ▸ | MLNR | O43193 | 1/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | PGR | P06401 | 1/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tegaserod SCHEMBL5180106 | 1.00 | HTR1A (0.66) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL6111051 | 0.99 | HTR1A (0.65) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL774764 | 0.99 | HTR1A (0.67) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL774763 | 0.99 | HTR1A (0.67) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL16464 | 0.99 | HTR1A (0.67) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL3635467 | 0.98 | HTR1A (0.66) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL4773941 | 0.98 | HTR1A (0.66) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL4961318 | 0.98 | HTR1A (0.66) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL4797293 | 0.98 | HTR1A (0.66) | HTR1AHTR2CADRB1ADRB3DRD2 | |
| Tegaserod SCHEMBL4961312 | 0.98 | HTR1A (0.66) | HTR1AHTR2CADRB1ADRB3DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070112056-A1 | Stable modifications of tegaserod hydrogen maleate | NOVARTIS AG (CH) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112056-A1 | Stable modifications of tegaserod hydrogen maleate | HRH2, HRH4, HRH1 | HTR4 12/4885HTR1A 23/4885HTR2C 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.